Remove Drug Delivery Remove Generic Drugs Remove Medicine
article thumbnail

Eli Lilly Partners with Amazon Pharmacy for Home Delivery of Drugs

XTalks

LillyDirect was launched at the beginning of this year to provide a digital end-to-end healthcare experience that includes access to the company’s drugs with home delivery and telehealth services. The subscription includes medicines for high cholesterol, anxiety and acid reflux.

Pharmacy 111
article thumbnail

Update: FDA clears first generic of AZ’s blockbuster Symbicort

pharmaphorum

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca’s top-selling respiratory drug Symbicort, although launch plans remain uncertain for now. The post Update: FDA clears first generic of AZ’s blockbuster Symbicort appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RxPass, Amazon’s New Prescription Drug Program, Offers Common Meds for a Flat Fee of $5

XTalks

The list of available medicines includes about 50 generic drugs. Amazon Pharmacy’s growing initiatives in the space, including RxPass and its prescription delivery and price-comparison site through Amazon PillPack, will be posing a threat to traditional drugstore giants like CVS Health Corp (CVS.N)

article thumbnail

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

The Pharma Data

Further to XPhyto’s press release dated January 18, 2021, the Company’s core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine. About XPhyto Therapeutics Corp.

Drugs 52
article thumbnail

XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact

The Pharma Data

Following a successful business year 2020, XPhyto is well positioned to execute on important core milestones in all business divisions, which include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment and development in psychedelic medicine.